Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_assertion type Assertion NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_head.
- NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_assertion description "[Using sequencing and/or immunohistochemical analyses, we investigated ATRX alterations (mutation/loss of expression) and their association with TP53 and IDH1 or IDH2 mutations in 140 adult WHO grade II, III and IV gliomas, 17 pediatric WHO grade II and III astrocytomas and 34 pilocytic astrocytomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_provenance.
- NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_assertion evidence source_evidence_literature NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_provenance.
- NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_assertion SIO_000772 22886134 NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_provenance.
- NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_assertion wasDerivedFrom befree-20140225 NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_provenance.
- NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_assertion wasGeneratedBy ECO_0000203 NP502109.RAHQd1JAqm3-NsfW5NEwbahryak5lLzqh6xJO94cRx_k0130_provenance.